Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance
NCT06923449
Summary
The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).
Eligibility
Inclusion Criteria: * pathology-confirmed diagnosis of gastric adenocarcinoma * age 18 years or older * surgical candidates with curative intent Exclusion Criteria: * Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD) * previous EMR or ESD (salvage surgery) * histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc) * unsufficient staging (unclear clinical stage at diagnosis) * emergency presentation (obstrucetd, significantly bleeding, perforated gastric cancer) * synchronous tumors affecting survival * pregnant patients * age \<18years
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06923449